推荐产品
等级
certified reference material
pharmaceutical secondary standard
质量水平
Agency
traceable to USP 1437600
API类
methylsulfonylmethane
CofA
current certificate can be downloaded
技术
HPLC: suitable
gas chromatography (GC): suitable
bp
238 °C (lit.)
mp
107-109 °C (lit.)
应用
pharmaceutical (small molecule)
格式
neat
储存温度
2-30°C
SMILES字符串
CS(C)(=O)=O
InChI
1S/C2H6O2S/c1-5(2,3)4/h1-2H3
InChI key
HHVIBTZHLRERCL-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
一般描述
用于质量控制的制药二级标准品，为制药实验室和制造商制备内部工作标准品提供了一种方便、高性价比的替代方案。
甲基磺酰甲烷是二甲基亚砜的氧化形式，通常存在于绿色植物、水果和蔬菜中。甲基磺酰甲烷可用作溶解多种溶质的溶剂，通常也用于高温反应。它具有药理特性，据报道可减轻外周疼痛、炎症和关节炎状况。
应用
这些二级标准品是合格的认证标准物质（CRM）。它们适用于多种分析应用，包括但不限于药物释放测试、药物的定性和定量分析方法开发、食品和饮料质量控制检测以及其他校准需求。
分析说明
这些二级标准品可追溯至USP、EP（PhEur）和BP一级标准品。
其他说明
该认证标准物质（CRM）根据ISO 17034 和 ISO/IEC 17025进行生产和认证。有关此CRM使用的所有信息均可在检验报告上找到。
附注
想要查看本品的检验报告示例，请在下框中输入LRAC3469。这只是一个示例证书，可能与您收到的批次不符。
WGK
WGK 1
闪点(°F)
Not applicable
闪点(°C)
Not applicable
Meta-analysis of the related nutritional supplements dimethyl sulfoxide and methylsulfonylmethane in the treatment of osteoarthritis of the knee
Brien S, et al.
Evidence-Based Complementary and Alternative Medicine (2011)
Methylsulfonylmethane (MSM). Monograph.
Alternative medicine review : a journal of clinical therapeutic, 8(4), 438-441 (2003-12-05)
Jacob F Smith et al.
Frontiers in physiology, 11, 80-80 (2020-03-07)
Osteoarthritis (OA) is a degenerative joint disease characterized by inflammatory degradation of articular cartilage and subchondral bone. Wogonin, a compound extracted from the plant Scutellaria baicalensis (colloquially known as skullcap), has previously been shown to have direct anti-inflammatory and antioxidative
S Brien et al.
Osteoarthritis and cartilage, 16(11), 1277-1288 (2008-04-18)
Conventional treatment of osteoarthritis (OA) with non-steroidal anti-inflammatory drugs is associated with serious gastrointestinal side effects and in view of the recent withdrawal of some cyclo-oxygenase-2 inhibitors, identifying safer alternative treatment options is needed. The objective of this systematic review
Youn Hee Joung et al.
International journal of oncology, 44(3), 883-895 (2014-01-10)
Human urinary bladder cancer is the fifth most common cancer, with a worldwide estimate of about two million patients. Recurrence after complete transurethral prostatic resection is the most important problem in therapy. Combination therapy is a new approach in the
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门